Merck & Co. Collaborates with Orion to Develop and Commercialise ODM-208 for US$290 M

By Ashish Tripathi

Pharma Deals Review: Vol 2022 Issue 7 (Table of Contents)

Published: 28 Jul-2022

DOI: 10.3833/pdr.v2022.i7.2708     ISSN: 1756-7874

Section: Research & Development



In a bid to bolster its prostate cancer pipeline, Merck &Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details